aripiprazole has been researched along with Smoking Cessation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, C; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
Nelson, R; Pumariega, AJ; Rotenberg, L | 1 |
Bao, YP; Beveridge, TJ; Di, XL; Li, SX; Liu, Y; Lu, L; Sun, HQ; Yang, FD | 2 |
3 trial(s) available for aripiprazole and Smoking Cessation
Article | Year |
---|---|
Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans.
Topics: Adult; Aripiprazole; Cocaine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Piperazines; Quinolones; Self Administration; Self Report; Smoking; Smoking Cessation; Treatment Outcome | 2014 |
Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Attention; Blood Pressure; China; Cognition; Cross-Over Studies; Cues; Data Interpretation, Statistical; Heart Rate; Humans; Male; Memory, Short-Term; Piperazines; Psychiatric Status Rating Scales; Psychomotor Performance; Quinolones; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2009 |
Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers.
Topics: Adult; Antipsychotic Agents; Aripiprazole; China; Double-Blind Method; Female; Humans; Male; Pilot Projects; Piperazines; Postprandial Period; Quinolones; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2010 |
1 other study(ies) available for aripiprazole and Smoking Cessation
Article | Year |
---|---|
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline | 2008 |